Page last updated: 2024-09-03

n,n-dimethylarginine and Diseases, Metabolic

n,n-dimethylarginine has been researched along with Diseases, Metabolic in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiarelli, F; Chiavaroli, V; de Giorgis, T; Diesse, L; Giannini, C; Marcovecchio, ML; Mohn, A	1
Bluck, L; Corander, M; Siervo, M; Stranges, S	1
Arnesen, H; Eid, HM; Hjerkinn, EM; Lyberg, T; Seljeflot, I	1
Abbasi, F; Chu, JW; Cooke, JP; Lamendola, C; McLaughlin, TL; Reaven, GM; Stühlinger, MC; Tsao, PS	1

Reviews

2 review(s) available for n,n-dimethylarginine and Diseases, Metabolic

Article	Year
Is asymmetric dimethylarginine associated with being born small and large for gestational age? Antioxidants & redox signaling, 2014, May-20, Volume: 20, Issue:15 Topics: Arginine; Biomarkers; Birth Weight; Cardiovascular Diseases; Female; Gestational Age; Humans; Metabolic Diseases; Pregnancy	2014
Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA). Nutrition, metabolism, and cardiovascular diseases : NMCD, 2011, Volume: 21, Issue:1 Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Endothelium, Vascular; Glucose; Glucose Tolerance Test; Heart Diseases; Humans; Hyperglycemia; Metabolic Diseases; Nitric Oxide; Oxidative Stress	2011

Article

Year

Is asymmetric dimethylarginine associated with being born small and large for gestational age?

Antioxidants & redox signaling, 2014, May-20, Volume: 20, Issue:15

Topics: Arginine; Biomarkers; Birth Weight; Cardiovascular Diseases; Female; Gestational Age; Humans; Metabolic Diseases; Pregnancy

2014

Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA).

Nutrition, metabolism, and cardiovascular diseases : NMCD, 2011, Volume: 21, Issue:1

Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Endothelium, Vascular; Glucose; Glucose Tolerance Test; Heart Diseases; Humans; Hyperglycemia; Metabolic Diseases; Nitric Oxide; Oxidative Stress

2011

Other Studies

2 other study(ies) available for n,n-dimethylarginine and Diseases, Metabolic

Article	Year
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism: clinical and experimental, 2004, Volume: 53, Issue:12 Topics: Aged; Arginine; Arteriosclerosis; Coronary Disease; Cross-Sectional Studies; Enzyme Inhibitors; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Nitric Oxide Synthase; Obesity; Risk Factors; Smoking	2004
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA, 2002, Mar-20, Volume: 287, Issue:11 Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents	2002

Article

Year

Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.

Metabolism: clinical and experimental, 2004, Volume: 53, Issue:12

Topics: Aged; Arginine; Arteriosclerosis; Coronary Disease; Cross-Sectional Studies; Enzyme Inhibitors; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Nitric Oxide Synthase; Obesity; Risk Factors; Smoking

2004

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.

JAMA, 2002, Mar-20, Volume: 287, Issue:11

Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents

2002